KLONOPIN (nda017533)- (0.125MG,0.25MG,0.5MG,1MG,2MG)

Generic Name	CLONAZEPAM	Innovator	CHEPLAPHARM
Dosage	0.125MG,0.25MG,0.5MG,1MG,2MG
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Klonopin is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures. Klonopin is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-V.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
6	0	5

Other Developers

Total Other Developers	5

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
0.125MG	**	**	-	-	-
0.25MG	**	**	-	-	-
0.5MG	**	**	Up	4	-
1MG	**	**	Down	-	4
2MG	**	**	-	4	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	4

Manufacturing Details of KLONOPIN